Home
About
Overview
Sharing Data
ORCID
Help
History (15)
The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium.
Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases.
IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner.
Ovulatory pheromone shortens ovarian cycles of female rats living in olfactory isolation.
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities. Clin Cancer Res. 2019 02 15; 25(4):1147-1155.
View in:
PubMed
subject areas
Acid Anhydride Hydrolases
Cisplatin
Dose-Response Relationship, Drug
Drug-Related Side Effects and Adverse Reactions
Genome-Wide Association Study
Genotype
Hearing Loss
Humans
Membrane Proteins
Neoplasms
Polymorphism, Single Nucleotide
Quality of Life
Risk Factors
authors with profiles
Mary Eileen Dolan